The 41st Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

Event Date:
4 – 5 December 2020
Location:
Virtual Meeting
View ProgramView Program

The 41st Annual Scientific meeting focuses on international collaboration in the pursuit of drug discovery and drug development. Richmond Pharmacology’s CEO, Jorg Taubel M.D. will be presenting three posters covering the following themes:

  • Meta-analysis of the effect of a meal on QTcF
  • Effect of Glucose Alone and in Collaboration with Moxifloxacin on Cardiac Repolaration in Male and Female Patents with Type I Diabetes
  • Effects of Progesterone and Estradiol on Subintervals over the Course of a Menstrual Cycle

Learn more about our Japanese Bridging Studies here or by using the View Publications link below.

Latest news

Upcoming Event

The 41st Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

4 – 5 December 2020
The 41st Annual Scientific meeting focuses on international collaboration in the pursuit of drug discovery and drug development.
View event

Marking a milestone for gene editing

November 10, 2020
We are pleased to share that Richmond Pharmacology, in partnership with Intellia Therapeutics and the Royal Free Hospital, have treated the first patient in a landmark CRISPR/Cas9 clinical trial of NTLA-2001
Read more

Richmond Pharmacology is delighted to confirm partnership with Intellia Therapeutics

October 20, 2020
Phase I study of Intellia Therapeutic’s NTLA-2001 for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN)
Read more

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 9, 2020
ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.
Read more